Core Concepts
Scientific Fundamentals Explained

Modification Highlight: When dT is Required For Modification Attachment

Many researchers are unaware that certain modifications may require the presence or addition of a specific nucleotide in their oligonucleotide sequence. These modifications come in many forms, including fluorophores, spacers, and attachment chemistry/linker modifications. The most common nucleotide that is introduced with these modifications is thymidine. Some of these modifications have “dT” included in their name, such as 3’ Biotin dT or Internal Fluorescein dT, while others are more difficult to identify. For example, Internal TAMRA NHS Ester (Figure 1) does not include dT in its name but is attached after oligonucleotide synthesis via an amino dT.

All internal NHS Esters and click-enabled modifications are attached through a thymidine residue after oligo synthesis. While most 3’ and 5’ modifications, including NHS Esters and click modifications, do not add an additional base to the oligo, 3’TAMRA in phosphoramidite form is one exception to this rule, as it is built from a dT residue.

Including a modification code (e.g., an internal TAMRA attachment) in your sequence during the ordering process will add a dT residue at that position. Thus, the modification code /i6-TAMN/ within the sequence TCGA/i6-TAMN/CGTA will incorporate a “T” nucleotide at that position. The final sequence will be: TCGA “T” CGTA, with TAMRA attached to the additional dT residue. It is therefore important for you to account for the nec¬essary dT base in your sequence prior to ordering, i.e., when assessing binding to a target sequence and in any calculations, such as melting temperature (Tm).

Figure 1. Internal TAMRA NHS Ester. The structure shows the link between the TAMRA NHS Ester (red) and the amino dT (blue) required in the sequence for addition of this modification.

Author: Michael Kammerer is the Manager of the Platinum HPLC Laboratories at IDT.